Cargando…

A Proteomic View at T Cell Costimulation

The “two-signal paradigm” in T cell activation predicts that the cooperation of “signal 1,” provided by the T cell receptor (TCR) through engagement of major histocompatility complex (MHC)-presented peptide, with “signal 2″ provided by costimulatory molecules, the prototype of which is CD28, is requ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lichtenfels, Rudolf, Rappl, Gunter, Hombach, Andreas A., Recktenwald, Christian V., Dressler, Sven P., Abken, Hinrich, Seliger, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335147/ https://www.ncbi.nlm.nih.gov/pubmed/22539942 http://dx.doi.org/10.1371/journal.pone.0032994

Ejemplares similares

Comparative Expression Profiling of Distinct T Cell Subsets Undergoing Oxidative Stress
por: Lichtenfels, Rudolf, et al.
Publicado: (2012)

Young T Cells Age During a Redirected Anti-Tumor Attack: Chimeric Antigen Receptor-Provided Dual Costimulation is Half the Battle
por: Hombach, Andreas A., et al.
Publicado: (2013)

IL12 integrated into the CAR exodomain converts CD8(+) T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors
por: Hombach, Andreas, et al.
Publicado: (2022)

OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells
por: Hombach, Andreas A., et al.
Publicado: (2012)

The CD3-Zeta Chimeric Antigen Receptor Overcomes TCR Hypo-Responsiveness of Human Terminal Late-Stage T Cells
por: Rappl, Gunter, et al.
Publicado: (2012)

Most Do, but Some Do Not: CD4(+)CD25(−) T Cells, but Not CD4(+)CD25(+) Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR)
por: Hombach, Andreas A., et al.
Publicado: (2017)

Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells
por: Chmielewski, Markus, et al.
Publicado: (2013)

Targeting two co-operating cytokines efficiently shapes immune responses
por: Hombach, Andreas A., et al.
Publicado: (2013)

Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia
por: Koehler, Philipp, et al.
Publicado: (2012)

IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
por: Hombach, Andreas A., et al.
Publicado: (2020)

Improved Activation toward Primary Colorectal Cancer Cells by Antigen-Specific Targeting Autologous Cytokine-Induced Killer Cells
por: Schlimper, Claudia, et al.
Publicado: (2012)

A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2(+) Solid Cancer
por: Hombach, Andreas A., et al.
Publicado: (2023)

Hydrogen peroxide – production, fate and role in redox signaling of tumor cells
por: Lennicke, Claudia, et al.
Publicado: (2015)

Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma
por: Seliger, Barbara, et al.
Publicado: (2009)

An Il12-Il2-Antibody Fusion Protein Targeting Hodgkin's Lymphoma Cells Potentiates Activation Of Nk And T Cells For An Anti-Tumor Attack
por: Jahn, Tobias, et al.
Publicado: (2012)

Loss of epithelium-specific GPx2 results in aberrant cell fate decisions during intestinal differentiation
por: Lennicke, Claudia, et al.
Publicado: (2017)

PECAM1(+)/Sca1(+)/CD38(+) Vascular Cells Transform into Myofibroblast-Like Cells in Skin Wound Repair
por: Etich, Julia, et al.
Publicado: (2013)

Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen Receptors
por: Abken, Hinrich
Publicado: (2021)

CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
por: Thomas, Simone, et al.
Publicado: (2023)

CAR T Cells: A Snapshot on the Growing Options to Design a CAR
por: Holzinger, Astrid, et al.
Publicado: (2019)

The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth
por: Schmidt, Patrick, et al.
Publicado: (2011)

The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation
por: Kraus, Anna K., et al.
Publicado: (2016)

New battlefields for costimulation
por: Martin-Orozco, Natalia, et al.
Publicado: (2006)

Chimeric antigen receptors designed to overcome transforming growth factor‐β‐mediated repression in the adoptive T‐cell therapy of solid tumors
por: Hartley, Jordan, et al.
Publicado: (2019)

ICOS costimulation is indispensable for the differentiation of T follicular regulatory cells
por: Panneton, Vincent, et al.
Publicado: (2023)

CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation
por: Barden, Markus, et al.
Publicado: (2023)

Editorial: Implementing Logic Gates in Adoptive Cell Therapy
por: Gross, Gideon, et al.
Publicado: (2022)

A Quantitative Assessment of Costimulation and Phosphatase Activity on Microclusters in Early T Cell Signaling
por: Witsenburg, J. Joris, et al.
Publicado: (2013)

Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance
por: Kaljanac, Marcell, et al.
Publicado: (2022)

Two pathways of costimulation through CD28
por: Miller, Jim, et al.
Publicado: (2009)

A pathway of costimulation that prevents anergy in CD28- T cells: B7- independent costimulation of CD1-restricted T cells
Publicado: (1995)

Inducible T-Cell Costimulator Ligand Plays a Dual Role in Melanoma Metastasis upon Binding to Osteopontin or Inducible T-Cell Costimulator
por: Raineri, Davide, et al.
Publicado: (2021)

Membrane Rafts in T Cell Activation: A Spotlight on CD28 Costimulation
por: Zumerle, Sara, et al.
Publicado: (2017)

Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials
por: Ormhøj, Maria, et al.
Publicado: (2022)

Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4(+) T cells to reduce the latent HIV(+) cell reservoir
por: Patasic, Lea, et al.
Publicado: (2020)

CD28, Costimulator or Agonist Receptor?
por: Margulies, David H.
Publicado: (2003)

Costimulation Blockade in Kidney Transplantation: An Update
por: Malvezzi, Paolo, et al.
Publicado: (2016)

Costimulation Blockade in Vascularized Composite Allotransplantation
por: Giannis, Dimitrios, et al.
Publicado: (2020)

Costimulation Blockade in Kidney Transplant Recipients
por: van der Zwan, Marieke, et al.
Publicado: (2019)

Role of Interleukin 12 and Costimulators in T Cell Anergy In Vivo
por: Parijs, Luk Van, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_aggl5qbmo1n33d5b2kufn7ecgr